Please login to the form below

Not currently logged in
Email:
Password:

Merck wins second court victory over Vioxx

New Orleans jury decides that painkiller was not responsible for heart attack of Florida man

Merck notched up a crucial victory in a US federal court, after a jury in New Orleans cleared the company of responsibility for the death of a man who took its painkiller Vioxx, since withdrawn.

The case was brought by the widow of Richard Irvin, who died of a heart attack in 2001 after taking Vioxx for less than a month.

In the two-week retrial of a case first heard in Houston in December, the jury of five men and three women took just over three hours to rule in favour of Merck.

The verdict will bolster Merck's chances of reducing potentially billions of dollars in liability for the drug, which was withdrawn after the company revealed it increased the risk of heart attacks and strokes after 18 months' continuous use.

ìThe evidence showed overwhelmingly that, for anything less than a very long use of Vioxx, there's not even the possibility of the drug causing increased heart-attack risk,î said Merck defence attorney Phil Beck. ìMr Irvin only took Vioxx for less than a month. He suffered multiple long-standing risk factors for a heart attack including partially clogged arteries. Mr Irvin would have suffered a heart attack when he did, whether he was taking Vioxx or not.î

Plaintiffs' attorney and lead counsel on the case, Andy Birchfield said he was ìdetermined to go forward on behalf of other victims of Vioxxî.

During the trial, the plaintiff suffered a setback when a pre-trial ruling by District Court Judge Eldon Fallon prevented an expert pathologist from testifying that Vioxx caused the blood clot that led to Irvin's heart attack.

Beck had argued that Irvin had a number of other cardiovascular risk factors, including his age, weight and high blood pressure.

After Hurricane Katrina struck last year, the case had been moved to Houston before Judge Fallon brought it back to New Orleans.

The victory is good news for Merck and means that it has now won more cases than it has lost.

The stage has now been set for two more Vioxx cases, which begin next month. The cases have been consolidated into one trial in New Jersey Superior Court, and both contain heart-attack victims. One of the cases will be fought by Mark Lanier, the Texas attorney who won the very first Vioxx trial last summer.

30th September 2008

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
KVA Digital

KVA is an award winning full-service digital communications & brand experience agency. Our healthcare expertise blends creative ‘outside-the-box’ thinking with...

Latest intelligence

Top 10 ways that Medical Affairs teams can leverage the Impetus InSite Platform®
Some of the most popular and innovative ways of using our cutting-edge asynchronous and synchronous virtual tools for Medical Affairs teams....
The power of communication: Engaging diverse groups in healthcare
Humans are diverse and communications to engage us need to be inclusive. It’s no longer about talking to a group, a cohort or an imagined section of society - especially...
Building the hospital of the future
Senior Consultant Leah Carlisle explores the growing trend of virtual hospitals and what it takes to develop a holistic digital ecosystem centered on the ultimate patient experience....